Dyne Therapeutics Inc. (DYN)
NASDAQ: DYN
· Real-Time Price · USD
12.21
-0.12 (-0.97%)
At close: Aug 19, 2025, 11:59 AM
Dyne Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 3.79M | 3.79M | 3.79M | 3.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 400K | 786K | 1.35M | 1.95M | 2.22M | 2.46M | 2.51M | 2.31M | 3.28M | 4.12M | 3.85M | 3.71M | 2.31M | 1.07M | 732K | 472K | 231K |
Gross Profit | n/a | -400K | -786K | 2.44M | 1.84M | 1.56M | 1.33M | -2.51M | -2.31M | -3.28M | -4.12M | -3.85M | -3.71M | -2.31M | -1.07M | -732K | -472K | -231K |
Operating Income | -440.93M | -397.1M | -343.89M | -314.47M | -271.08M | -265.85M | -242.16M | -214.62M | -194.63M | -180.64M | -170.96M | -182.78M | -183.26M | -160.67M | -150.03M | -126.67M | -97.42M | -75.93M |
Interest Income | 30.59M | 31.02M | 26.92M | 21.08M | 13.99M | 9.15M | 7.64M | 7.23M | 5.95M | 4.18M | 2.92M | 1.76M | 1.04M | 806K | 742K | 592K | 408K | 198K |
Pretax Income | -412.88M | -367.13M | -317.42M | -294.51M | -257.6M | -257.4M | -235.94M | -208.13M | -189.3M | -176.7M | -168.1M | -181.06M | -182.25M | -159.91M | -149.29M | -126.15M | -97.49M | -76.52M |
Net Income | -412.88M | -367.13M | -317.42M | -294.51M | -257.6M | -257.4M | -234.25M | -205.12M | -185.4M | -172.8M | -165.69M | -179.96M | -182.06M | -159.71M | -149.29M | -126.15M | -97.49M | -76.52M |
Selling & General & Admin | 60.64M | 53.79M | 62.48M | 55.45M | 49.62M | 47.52M | 30.83M | 29.51M | 30.1M | 28.58M | 28.2M | 30.91M | 29.55M | 29.75M | 28.72M | 25.56M | 23.14M | 18.19M |
Research & Development | 380.29M | 343.31M | 281.41M | 258.45M | 220.9M | 217.76M | 210.76M | 185.11M | 164.53M | 152.06M | 142.76M | 151.87M | 153.71M | 130.92M | 121.31M | 101.11M | 74.27M | 57.74M |
Other Expenses | n/a | n/a | 506K | 506K | 506K | 133K | 904K | 2.22M | 2.21M | 2.6M | 1.32M | 176K | 185K | 175K | 175K | -49K | -49K | -49K |
Operating Expenses | 440.93M | 397.1M | 343.89M | 313.9M | 270.51M | 265.29M | 241.59M | 214.62M | 194.63M | 180.64M | 170.96M | 182.78M | 183.26M | 160.67M | 150.03M | 126.67M | 97.42M | 75.93M |
Interest Expense | -94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 81K | 211K | 338K |
Selling & Marketing Expenses | n/a | n/a | n/a | -567K | -567K | -567K | -567K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 325.93M | 397.89M | 344.67M | 314.47M | 271.08M | 265.85M | 242.16M | 214.62M | 194.63M | 180.64M | 170.96M | 182.78M | 183.26M | 160.67M | 150.03M | 126.67M | 97.42M | 75.93M |
Income Tax Expense | n/a | n/a | n/a | n/a | -431K | -431K | -2.12M | -3.44M | -3.9M | -4.34M | -2.85M | -1.35M | -275K | 376K | 742K | 343K | 159K | -104K |
Shares Outstanding (Basic) | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M | 49.47M |
Shares Outstanding (Diluted) | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M | 49.47M |
EPS (Basic) | -3.86 | -3.59 | -3.35 | -3.56 | -3.59 | -3.97 | -3.91 | -3.53 | -3.32 | -3.25 | -3.19 | -3.48 | -3.53 | -3.1 | -2.91 | -2.55 | -2.03 | -1.67 |
EPS (Diluted) | -3.86 | -3.59 | -3.35 | -3.56 | -3.59 | -3.97 | -3.91 | -3.53 | -3.32 | -3.25 | -3.19 | -3.48 | -3.53 | -3.1 | -2.91 | -2.55 | -2.03 | -1.67 |
EBITDA | -439.54M | -395.71M | -342.61M | -313.24M | -269.86M | -264.21M | -240.49M | -213.34M | -193.38M | -179.38M | -169.68M | -180.98M | -181.6M | -159.23M | -148.76M | -125.67M | -96.78M | -75.56M |
EBIT | -325.14M | -397.1M | -343.89M | -314.47M | -271.08M | -265.85M | -242.16M | -214.62M | -194.62M | -180.64M | -170.96M | -182.6M | -183.09M | -160.29M | -149.47M | -126.26M | -97.28M | -76.18M |
Depreciation & Amortization | 1.39M | 1.79M | 1.67M | 1.79M | 1.95M | 2.22M | 2.46M | 2.51M | 2.31M | 3.28M | 4.12M | 3.85M | 3.71M | 2.31M | 1.07M | 949K | 864K | 781K |